Debt (Narrative) (Detail) (USD $)	12 Months Ended			12 Months Ended		1 Months Ended				12 Months Ended	1 Months Ended	12 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2012	Jun. 30, 2012 Revolving Credit Facility [Member]	Jun. 30, 2011 Revolving Credit Facility [Member]	Jun. 30, 2011 Mortgages [Member]	Jun. 30, 2012 Medium-term Notes [Member] Installment	Jun. 30, 2011 Medium-term Notes [Member]	Dec. 31, 2010 Medium-term Notes [Member]	Dec. 31, 2010 Medium-term Notes [Member] Rising Pharmaceuticals Inc. [Member]	Jun. 30, 2011 Foreign Line of Credit [Member]	Jun. 30, 2012 Foreign Line of Credit [Member]	Jun. 30, 2011 Foreign Line of Credit [Member]	Jun. 30, 2010 Foreign Line of Credit [Member]
Debt Instrument [Line Items]
Revolving loans, maximum amount				$ 40,000,000					$ 40,000,000
Revolving loans, expiration date				Dec. 31, 2015
Proceeds from bank loans	65,050,000	550,000		11,000
Bank loans, interest rate				2.25%		5.92%	2.25%
Proceeds from term loans used to finance business acquisition										40,000,000
Bank loans outstanding	51,050,000		42,000,000	11,000,000	14,050,000		31,000,000	37,000,000
Term loans, number of installments							20
Short term loans payable	6,247,000		6,713,000				6,500,000
Letters of credit	145,000		199,000
Lines of credit, additional borrowing during the period											50,000
Lines of credit, remaining borrowing capacity											20,423,000	8,378,000	20,423,000
Lines of credit, interest rate												5.50%	0.94%	1.10%
Lines of credit, interest rate over and above LIBOR													0.75%
Bank loans, unused borrowing capacity	49,278,000		37,179,000
Mortgage payable	$ 3,947,000		$ 3,765,000			$ 3,947,000
Mortgage payable, amortization period						20 years